Key result
A P2Y12 reaction unit (PRU) value ≤ 153 at 12-48 hours after percutaneous coronary intervention was associated with a lower risk of non-fatal ischemic stroke at 12 months.
Why the study?
In patients undergoing PCI with a stent, high on-treatment platelet reactivity may be associated with an increased risk of stroke.
Does high on-treatment platelet reactivity increase the risk of non-fatal stroke in patients undergoing percutaneous coronary intervention?
Observational (n=5,906)
Yes
Does high on-treatment platelet reactivity increase the risk of non-fatal stroke in patients undergoing percutaneous coronary intervention?
High on-treatment platelet reactivity (PRU > 153) at 12-48 hours post-PCI is associated with an increased risk of non-fatal ischemic stroke at 12 months in Japanese patients.
Answers are grounded in this paper and cite their sources.
High PRU may flag elevated post-PCI stroke risk; hypothesis-generating for PRU-guided therapy trials.
In patients undergoing percutaneous coronary intervention (PCI) with a stent, high on-treatment platelet reactivity may be associated with an increased risk of stroke. This post hoc analysis of the PENDULUM registry compared the risk of post-PCI stroke according to on-treatment P2Y12 reaction unit (PRU) values. Patients aged ≥ 20 years who underwent PCI were stratified by baseline PRU (at 12 and 48 h post-PCI) as either high (HPR, > 208), optimal (OPR, > 85 to ≤ 208), or low on-treatment platelet reactivity (LPR, ≤ 85). The incidences of non-fatal ischemic and non-ischemic stroke through to 12 months post-PCI were recorded. Almost all enrolled patients (6102/6267 [97.4%]) had a risk factor for ischemic stroke, and most were receiving dual antiplatelet therapy. Of the 5906 patients with PRU data (HPR, n = 2227; OPR, n = 3002; LPR, n = 677), 47 had a non-fatal stroke post-PCI (cumulative incidence: 0.68%, ischemic; 0.18%, non-ischemic stroke). Patients with a non-fatal ischemic stroke event had statistically significantly higher post-PCI PRU values versus those without an event (P = 0.037). The incidence of non-fatal non-ischemic stroke was not related to PRU value. When the patients were stratified by PRU ≤ 153 versus > 153 at 12–48 h post-PCI, a significant difference was observed in the cumulative incidence of non-fatal stroke at 12 months (P = 0.044). We found that patients with ischemic stroke tended to have higher PRU values at 12–48 h after PCI versus those without ischemic stroke. Clinical trial registration: UMIN000020332.
No takes yet. Share an insight, caveat, or question.
Matsumaru et al. (2022) conducted an observational in percutaneous coronary intervention (PCI) with a stent (n=5,906). P2Y12 reaction unit (PRU) ≤ 153 vs. PRU > 153 was evaluated on Non-fatal ischemic stroke at 12 months (HR 0.43, 95% CI 0.19-0.98, p=0.044). A P2Y12 reaction unit (PRU) value ≤ 153 at 12-48 hours after percutaneous coronary intervention was associated with a lower risk of non-fatal ischemic stroke at 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: